These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 35047554)

  • 61. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Development of a macrophages-related 4-gene signature and nomogram for the overall survival prediction of hepatocellular carcinoma based on WGCNA and LASSO algorithm.
    Yang Z; Zi Q; Xu K; Wang C; Chi Q
    Int Immunopharmacol; 2021 Jan; 90():107238. PubMed ID: 33316739
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A necroptosis -related signature for predicting prognosis and immunotherapy in hepatocellular carcinoma.
    Fu X; Yang Y; Zhang X
    Front Genet; 2022; 13():919599. PubMed ID: 36134033
    [No Abstract]   [Full Text] [Related]  

  • 64. A Novel Expression Signature from the Perspective of Mesenchymal-Epithelial Transition for Hepatocellular Carcinoma with Regard to Prognosis, Clinicopathological Features, Immune Cell Infiltration, Chemotherapeutic Efficacy, and Immunosuppressive Molecules.
    Xu L; Zheng Q
    J Oncol; 2021; 2021():5033416. PubMed ID: 34367283
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Non-Apoptotic Programmed Cell Death-Related Gene Signature Correlates With Stemness and Immune Status and Predicts the Responsiveness of Transarterial Chemoembolization in Hepatocellular Carcinoma.
    Zhang G; Fan W; Wang H; Wen J; Tan J; Xue M; Li J
    Front Cell Dev Biol; 2022; 10():844013. PubMed ID: 35573678
    [No Abstract]   [Full Text] [Related]  

  • 66. Development of a novel lipid metabolism-based risk score model in hepatocellular carcinoma patients.
    Wang W; Zhang C; Yu Q; Zheng X; Yin C; Yan X; Liu G; Song Z
    BMC Gastroenterol; 2021 Feb; 21(1):68. PubMed ID: 33579192
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A Novel Epithelial-Mesenchymal Transition Gene Signature Correlated With Prognosis, and Immune Infiltration in Hepatocellular Carcinoma.
    Kong W; Mao Z; Han C; Ding Z; Yuan Q; Zhang G; Li C; Wu X; Chen J; Guo M; Hong S; Yu F; Liu R; Wang X; Zhang J
    Front Pharmacol; 2022; 13():863750. PubMed ID: 35517787
    [No Abstract]   [Full Text] [Related]  

  • 68. A novel pyroptosis-related signature predicts prognosis and response to treatment in breast carcinoma.
    Yu H; Fu Y; Tang Z; Jiang L; Qu C; Li H; Tan Z; Shu D; Peng Y; Liu S
    Aging (Albany NY); 2022 Jan; 14(2):989-1013. PubMed ID: 35085103
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Screening and identification of angiogenesis-related genes as potential novel prognostic biomarkers of hepatocellular carcinoma through bioinformatics analysis.
    Zhen Z; Shen Z; Hu Y; Sun P
    Aging (Albany NY); 2021 Jul; 13(13):17707-17733. PubMed ID: 34252885
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A signature of 33 immune-related gene pairs predicts clinical outcome in hepatocellular carcinoma.
    Sun XY; Yu SZ; Zhang HP; Li J; Guo WZ; Zhang SJ
    Cancer Med; 2020 Apr; 9(8):2868-2878. PubMed ID: 32068352
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma.
    Peng Y; Liu C; Li M; Li W; Zhang M; Jiang X; Chang Y; Liu L; Wang F; Zhao Q
    Cancer Cell Int; 2021 Feb; 21(1):98. PubMed ID: 33568167
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A novel tumor doubling time-related immune gene signature for prognosis prediction in hepatocellular carcinoma.
    Zhang G; Su L; Lv X; Yang Q
    Cancer Cell Int; 2021 Oct; 21(1):522. PubMed ID: 34627241
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A novel pyroptosis-associated gene signature for immune status and prognosis of cutaneous melanoma.
    Wu Z; Chen L; Jin C; Xu J; Zhang X; Yao Y
    PeerJ; 2021; 9():e12304. PubMed ID: 34721986
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Roles of Pyroptosis-Related Gene Signature in Prediction of Endometrial Cancer Outcomes.
    Chen Y; Liao Y; Du Q; Shang C; Qin S; Lee K; Zou Q; Liu J; Yao S
    Front Med (Lausanne); 2022; 9():822806. PubMed ID: 35299842
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Identification of Novel Tumor Microenvironment-Related Long Noncoding RNAs to Determine the Prognosis and Response to Immunotherapy of Hepatocellular Carcinoma Patients.
    Huang S; Zhang J; Lai X; Zhuang L; Wu J
    Front Mol Biosci; 2021; 8():781307. PubMed ID: 35004851
    [No Abstract]   [Full Text] [Related]  

  • 76. A Novel Pyroptosis-Related lncRNAs Signature for Predicting the Prognosis of Kidney Renal Clear Cell Carcinoma and Its Associations with Immunity.
    Tang X; Zhang A; Feng Y; Su Y; Wang X; Jiang F; Ma J
    J Oncol; 2021; 2021():9997185. PubMed ID: 34764994
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Identification of a Novel Pyroptosis-Related Gene Signature Indicative of Disease Prognosis and Treatment Response in Skin Cutaneous Melanoma.
    Li AA; Zhang Y; Tong WL; Chen JW; Huang SH; Liu JM; Liu ZL
    Int J Gen Med; 2022; 15():6145-6163. PubMed ID: 35855761
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Identification of immune-related lncRNA signature for predicting immune checkpoint blockade and prognosis in hepatocellular carcinoma.
    Xu Q; Wang Y; Huang W
    Int Immunopharmacol; 2021 Mar; 92():107333. PubMed ID: 33486322
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Identification pyroptosis-related gene signature to predict prognosis and associated regulation axis in colon cancer.
    Zhou K; Gu X; Tan H; Yu T; Liu C; Ding Z; Liu J; Shi H
    Front Pharmacol; 2022; 13():1004425. PubMed ID: 36249755
    [No Abstract]   [Full Text] [Related]  

  • 80. A novel necroptosis-related lncRNA signature predicts the prognosis and immune microenvironment of hepatocellular carcinoma.
    Wang J; Shen B; Liu X; Jiang J
    Front Genet; 2022; 13():985191. PubMed ID: 36267408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.